COST-EFFECTIVENESS OF PLERIXAFOR PLUS GCSF FOR MOBILIZATION OF PERIPHERAL BLOOD STEM CELLS IN PATIENTS WITH MYELOMA AND LYMPHOMA IN SPAIN

被引：0
|
作者：
Duarte, R. F. [1 ]
Perez-Simon, J. A. [2 ]
Martin, G. [3 ]
de la Rubia, J. [4 ]
Marin, P. [5 ]
Alvarez, M. A. [6 ]
Espinos, B. [7 ]
Roset, M. [7 ]
机构：
[1] Hosp Duran & Reynals, Inst Catala Oncol, Lhospitalet De Llobregat, Spain
[2] Hosp Univ Virgen del Rocio, Seville, Spain
[3] Banc Sang & Teixits, Barcelona, Spain
[4] Hosp Univ La Fe Valencia, Valencia, Spain
[5] Hosp Clin Barcelona, Barcelona, Spain
[6] Hosp Reina Sofia, Cordoba, Spain
[7] IMS Hlth, Barcelona, Spain
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 07期
关键词：
D O I：
10.1016/j.jval.2012.08.2118
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A423 / A423
页数：1
相关论文
共 50 条
  • [1] THE EFFECTIVENESS AND COST EFFECTIVENESS OF PLERIXAFOR plus GCSF VERSUS GCSF ± CHEMOTHERAPY AS SALVAGE MOBILIZATION REGIMENS IN LYMPHOMA AND MULTIPLE MYELOMA PATIENTS
    Tuffaha, H. W.
    Hussein, A. A.
    Sharma, S.
    Abu-Jazar, H.
    Al-Rawi, O. S.
    Saad, A. M.
    Al-Zaben, A.
    Hussein, N.
    Abdel-Rahman, F. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S247 - S247
  • [2] Cost-Effectiveness of Hematopoietic Stem Cell Mobilization Strategies Including Plerixafor in Multiple Myeloma and Lymphoma Patients
    Ales, Tichopad
    Veronika, Vitova
    Zdenek, Koristek
    Daniel, Lysak
    JOURNAL OF CLINICAL APHERESIS, 2013, 28 (06) : 395 - 403
  • [3] GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: Collection effectiveness and cost effectiveness analysis
    Abdel-Rahman, Fawzi
    Tuffaha, Haitham W.
    Sharma, Shanta
    Abu Jazar, Husam
    Hussein, Nilly
    Saad, Adnan
    Al Rawi, Omar
    Hussein, Ayad
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2014, 20 (02) : 130 - 136
  • [4] COST-EFFECTIVENESS OF PLERIXAFOR (PXF) FOR STEM CELL MOBILIZATION IN LYMPHOMA (NHL/HL) AND MULTIPLE MYELOMA (MM) PATIENTS IN POLAND
    Kaczor, M. P.
    Wojcik, R.
    Pawlik, D.
    Glasek, M.
    Pieczonka, A.
    Lis, J.
    VALUE IN HEALTH, 2013, 16 (07) : A384 - A385
  • [5] COMPARATIVE COST UTILITY ANALYSIS OF PLERIXAFOR PLUS GCSF VERSUS CYCLOPHOSPHAMIDE PLUS GCSF AS SALVAGE MOBILIZATION REGIMENS IN MULTIPLE MYELOMA PATIENTS
    Tuffaha, H. W.
    Hussein, A. A.
    Abdel-Rahman, F. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S248 - S248
  • [6] Use of plerixafor in patients with Hodgkin lymphoma with poor mobilization of peripheral blood stem cells
    Yuan, Shan
    Nademanee, Auayporn
    Forman, Stephen J.
    Wang, Shirong
    LEUKEMIA & LYMPHOMA, 2013, 54 (03) : 646 - 648
  • [7] An Algorithmic Approach TO Pre-Emptive Plerixafor Usage with Gcsf Alone For Mobilization of Peripheral Blood Stem Cells in Multiple Myeloma
    Kodad, Shruthi
    Aggarwal, Vibhuti
    Stakiw, Julie
    Sabry, Waleed
    Bosch, Mark
    Sarker, Sabuj
    Elemary, Mohamed
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 330 - 330
  • [8] Reversible mobilization of lymphoma cells to the peripheral blood by Plerixafor
    El Dika, Imane
    Mokadem, Hiba
    Bazarbachi, Ali
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S225 - S225
  • [9] Cost-Effectiveness Analysis of Motixafortide Versus Plerixafor in Stem Cell Mobilization for Autologous Transplantation in Patients with Multiple Myeloma
    Lamotte, Mark
    DiPersio, John F.
    Siegel, David
    Meron, Haddas
    Gerlier, Laetitia
    BLOOD, 2022, 140 : 10794 - 10795
  • [10] First experience of the use of a generic of plerixafor in peripheral blood stem cell mobilization in multiple myeloma and lymphoma patients
    Bekadja, M. A.
    Mansour, B.
    Ouldjeriouat, H.
    Entasoltan, B.
    Bouchama, S.
    Charef, L.
    Amani, K.
    Hakiki, N.
    Bouamama, F.
    Osmani, S.
    Brahimi, M.
    Arabi, A.
    Bouhass, R.
    Yafour, N.
    TRANSFUSION AND APHERESIS SCIENCE, 2021, 60 (03)
12345